Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trial
Titel:
Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trial
Auteur:
Kalinsky, K. Diamond, J.R. Vahdat, L.T. Tolaney, S.M. Juric, D. O'Shaughnessy, J. Moroose, R.L. Mayer, I.A. Abramson, V.G. Goldenberg, D.M. Sharkey, R.M. Maliakal, P. Hong, Q. Goswami, T. Wegener, W.A. Bardia, A.